Cited by 240Ovarian function and disordersReproductive Health and TechnologiesReproductive Biology and Fertility

Prospective randomized trial comparing the effects of letrazole (LE) and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation prior to intrauterine insemination (IUI).

Open access
Sammour, A, Biljan, M.M, Tan, S.L, Tulandi, T·2001·Fertility and Sterility

Integrity signals

Registry

Crossref · 10.1016/s0015-0282(01)02323-8

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In superovulation, letrozole is associated with few developing follicles and thick endometrium.

    “In superovulation, letrozole is associated with few developing follicles and thick endometrium.”

    From A new era in ovulation induction (2006) · cites this paper as [54]

  • The use of letrozole for superovulation is associated with a pregnancy rate higher than with the use of clomiphene citrate (CC) (16.7% vs. 5.6%).

    “The use of letrozole for superovulation is associated with a pregnancy rate higher than with the use of clomiphene citrate (CC) (16.7% vs. 5.6%).”

    From A new era in ovulation induction (2006) · cites this paper as [54]

  • In that trial, there is a trend for a higher pregnancy rate in the letrozole group than in the CC group (16.7% vs. 5.6%).

    “Moreover, there is a trend for a higher pregnancy rate in the letrozole group than in the CC group (16.7% vs. 5.6%).”

    From A new era in ovulation induction (2006) · cites this paper as [54]

  • In a randomized trial of 49 patients with unexplained infertility, letrozole treatment was associated with a lower E2 level, fewer follicles (1 vs. 2), thicker endometrium (8.6 mm vs. 6.9 mm), and more stromal blood flow compared with CC.

    “Compared with CC, letrozole treatment was associated with a lower E 2 level, fewer follicles (1 vs. 2), thicker endometrium (8.6 mm vs. 6.9 mm), and more stromal blood flow.”

    From A new era in ovulation induction (2006) · cites this paper as [54]

  • The ideal dose of letrozole for superovulation or ovulation induction remains unknown.

    “The ideal dose of letrozole for superovulation or ovulation induction is still unknown.”

Cited by

Sorted by citations

Authors
Sammour, A., Biljan, M. M., Tan, S. L., & Tulandi, T.
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
2001-09
Volume
76
Issue
3
Pages
S110
ISSN
0015-0282 (ISSN-L)
OpenAlex
W1987948244
Cited by
238
References
0
Citations by year
2022: 2 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 30 · 2016: 7 · 2015: 38 · 2014: 31 · 2013: 22 · 2012: 34
FWCI
2.45
Type
journal article
Language
en
Open access
Locations
Fertility and Sterility (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
Keywords
clomiphene citrate, ovulation induction, intrauterine insemination, unexplained infertility, endometrial thickness, folliculogenesis, pregnancy rate, aromatase inhibitors, estradiol, follicle-stimulating hormone, endometrial receptivity, hCG trigger, endometrial receptivity index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review